Prurigo Nodularis Clinical Trial
Barzolvolimab, an investigational inflammation treatment, had success in treating hives (urticaria). Could it also be used to treat prurigo nodularis?
Center for Dermatology Clinical Research in Fremont, CA is conducting a new clinical study assessing the efficacy and safety of barzolvolimab in patients with prurigo nodularis (PN).
Study Overview
Who Qualifies? Patients with severe itch due to PN
Study Duration: 40 Weeks
Study Purpose: To evaluate the clinical effect of barzolvolimab on itch response
Protocol: CDX0159-10
